Important Notes
| Applicants are strongly advised to read the instructions and eligibility criteria before starting an application. |
| Letters of Intent (LOI) are available on the Foundant Technologies Website. |
| You must be invited to submit a full application. |
Anticipated Timeline
| July 20, 2021 | Letter of Intent Period Opens |
| September 14, 2021 | Deadline for Letter of Intent due by 11:59 pm Eastern Time |
| December 1, 2021 | Invitation from Scientific Advisory Committee for Full Applications |
| January 11, 2022 | Full Application Deadline due by 11:59 pm Eastern Time |
| March 2022 | Grantee Notification |
| April/May 2022 | Grant Start Date |
Current Partner Grant Opportunities
 |
ATS/Alpha-1 Foundation Research Grant
1 grant available |
| Target Audience: Investigators (junior or established) interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1) |
| The focus of this research grant is proposals that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) or established investigators at any stage in their career • Applicants must not be current awardees of the Alpha-1 Foundation Research Program • Must meet eligibility requirements for all grants found here |
| Co-funded by the ATS and the Alpha-1 Foundation. |
  |
ALA/ATS/CHEST Foundation Respiratory Health Equity Research Award
2 grants available$100,000 per year for 2 years |
Target Audience:
|
|
The focus of these research grants is clinical research that addresses topics on improving clinical outcomes in preventing and/or treating lung disease that disproportionately affects under-represented minority (URM) patient groups. URM patient groups includes patients from lower-middle- and low-income countries as defined by the World Bank, or the following North American populations: African Americans, Mexican-Americans, Native Americans (American Indians, Alaska Natives, and Native Hawaiians), Pacific Islanders, and mainland Puerto Ricans. Applicants may request up to $100,000 per year for two years for salaries, supplies, or a combination of these two. No more than 20% of the budget can be for salary. Indirect costs will not be paid to the sponsoring institution. Recipients will also be eligible for complimentary registration and a $1,000 travel stipend to attend both the ATS International Conference and CHEST Annual Meeting up to one year past conclusion of the research to present data. |
Award-specific eligibility:
|
| Co-funded by the American Lung Association, ATS, and the CHEST Foundation. |
 |
ATS/COPD Foundation Research Grant
1 grant available |
| Target Audience: Investigators interested in research that is relevant to non-CF Bronchiectasis |
|
The focus of this research grant is proposals that have a high likelihood to advance the understanding of the pathophysiology of non-CF Bronchiectasis. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution |
| Award-specific eligibility: • Junior investigators (as defined here) or established investigators at any stage in their career • Must meet eligibility requirements for all grants found here |
| Co-funded by the ATS and the COPD Foundation. Please visit bronchiectasisandntminitiative.org for more information about our partner. |
 |
ATS/Foundation for Sarcoidosis Research Grant
1 grant available$25,000 per year for 2 years |
| Target Audience: Eary career investigators interested in research that is relevant to sarcoidosis |
|
The focus of this research grant is proposals that advance research in the area of sarcoidosis. Applicants may request up to $25,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) • Must meet eligibility requirements for all grants found here |
| Co-funded by the ATS and the Foundation for Sarcoidosis Research. |
Review Process
Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.
The ATS Scientific Grant Review Committee (SGRC)* will review the applications at the end of February/beginning of March 2022. The membership of the SGRC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.
*previously known as the Scientific Advisory Committee (SAC)
ATS Policy on Additional Grant Funding
Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SGRC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.
If your question is not answered in the FAQ, contact the Research Program at researchprogram@thoracic.org.
